Drug Discoveries & Therapeutics

Drug Discoveries & Therapeutics

Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement

1,175 registered articles
(updated on August 26, 2025)

Online ISSN : 1881-784X
Print ISSN : 1881-7831
ISSN-L : 1881-7831

JOURNAL PEER REVIEWED FREE ACCESS ADVANCE PUBLICATION
Scopus Pubmed

2025 Volume 19 Issue 3

Kampo medicine in the management of menopausal symptoms: A narrative review of therapeutic potential Yuanzheng Liu, Susumu Kobayashi, Ling Wang, Yanming Ren, Peipei Song
Primary cutaneous lymphoma is a microsatellite stable tumor: An analysis of microsatellite instability Saki Maeda-Otsuka, Myangat Tselmeg Mijiddorj, Ikko Kajihara, Soichiro Sawamura, Katsunari Makino, Shinichi Masuguchi, Satoshi Fukushima
Abortion adverse events associated with adalimumab, etanercept, ustekinumab, and dupilumab during pregnancy: A pharmacovigilance study based on FDA adverse event reporting system Qian Liu, Yang Wang, Panwei Hu, Peizhi He
Quercetin as a multifaceted therapeutic agent in recurrent pregnancy loss: Mechanisms and clinical perspectives Qing Qi, Jing Zhou, Jing Wang, Yiyuan Zhou, Hongmei Sun, Ling Wang

View all articles in current issue

Most viewed articles (July 2025)

1

Acoltremon: The first TRPM8 agonist approved for the treatment of dry eye disease

Released on J-STAGE: July 04, 2025 | Volume 19 Issue 3 Pages 210-211

Yang Zhou, Wenzhu Zhang, Fusheng Sun
2

Suzetrigine: The first Nav1.8 inhibitor approved for the treatment of moderate to severe acute pain

Released on J-STAGE: March 06, 2025 | Volume 19 Issue 1 Pages 80-82

Shasha Hu, Dong Lyu, Jianjun Gao
3

Role of inulin as prebiotics on inflammatory bowel disease

Released on J-STAGE: March 16, 2019 | Volume 13 Issue 1 Pages 1-8

Wasim Akram, Navneet Garud, Ramakant Joshi
4

Abortion adverse events associated with adalimumab, etanercept, ustekinumab, and dupilumab during pregnancy: A pharmacovigilance study based on FDA adverse event reporting system

Released on J-STAGE: July 04, 2025 | Volume 19 Issue 3 Pages 160-173

Qian Liu, Yang Wang, Panwei Hu, Peizhi He
5

Acoltremon: The first TRPM8 agonist approved for the treatment of dry eye disease

Released on J-STAGE: June 27, 2025 | Article ID 2025.01048

Yang Zhou, Wenzhu Zhang, Fusheng Sun

Favorites & Alerts

Top